Drug Shortage Report for AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
| Report ID | 162481 |
| Drug Identification Number | 02470780 |
| Brand name | APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN |
| Common or Proper name | LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE |
| Strength(s) | 500MG 500MG 30MG |
| Dosage form(s) | TABLET CAPSULE KIT CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | A02BD |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-08 |
| Estimated end date | 2022-06-30 |
| Actual end date | 2022-06-27 |
| Shortage status | Resolved |
| Updated date | 2022-06-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-06-30 | French | Compare |
| v3 | 2022-06-30 | English | Compare |
| v2 | 2022-06-12 | French | Compare |
| v1 | 2022-06-12 | English | Compare |
Showing 1 to 4 of 4